Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide

This publication has 10 references indexed in Scilit:

• Treatment of adenocarcinoma of the pancreas with somatostatin and gonadoliberin (Luteinizing hormone-releasing hormone)
  The American Journal of Surgery, 1992
• Therapeutic effect of the gastrin receptor antagonist, CR2093 on gastrointestinal tumour cell growth
  British Journal of Cancer, 1992
• Somatostatin and Analogues in the Treatment of Cancer
  Annals of Surgery, 1991
• Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects
  British Journal of Cancer, 1990
• Growth effects of regulatory peptides on human pancreatic cancer lines PANC-1 and MIA PaCa-2
  Gastroenterology, 1990
• Effects of a high-fat diet and L364,718 on growth of human pancreas cancer
  Digestive Diseases and Sciences, 1990
• Membrane Receptors for Peptides in Experimental and Human Pancreatic Cancers
  Pancreas, 1989
• Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995
  The American Journal of Surgery, 1988
• LIGAND: A versatile computerized approach for characterization of ligand-binding systems
  Analytical Biochemistry, 1980
• Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic Rats
  Diabetes, 1963